Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Healthcare & Life Sciences Private Equity Deal Tracker: Radius Health Raises $43 Million in New VC Funding

Posted in Life Sciences Investing

Radius Health, Inc., has announced it has completed a new equity financing of $43 million.

Radius, based in a Cambridge, Mass., is a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women’s health conditions.

The financing was led by F2 Biosciences III, L.P. F2 is a family of life science funds established by Morana Jovan-Embiricos

Participation also came from the following existing investors: Biotech Growth N.V., MPM Capital, Brookside Capital, MPM Bio IV NVS Strategic Fund and BB Biotech Ventures. 

Radius intends to use the funding to support its clinical development programs for BA058, the company’s anabolic, bone-building compound developed for the treatment of patients with osteoporosis at high risk of fracture.


We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.